An Alternative Terminal Step of the General Secretory Pathway in Staphylococcus aureus.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 4542188)

Published in MBio on August 18, 2015

Authors

Arryn Craney1, Melissa M Dix2, Ramkrishna Adhikary1, Benjamin F Cravatt2, Floyd E Romesberg3

Author Affiliations

1: Department of Chemistry, The Scripps Research Institute, La Jolla, California, USA.
2: The Skaggs Institute for Chemical Biology and Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California, USA.
3: Department of Chemistry, The Scripps Research Institute, La Jolla, California, USA floyd@scripps.edu.

Articles cited by this

Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol (2001) 28.01

A possible precursor of immunoglobulin light chains. Nat New Biol (1972) 11.03

Protein translocation across the bacterial cytoplasmic membrane. Annu Rev Biochem (2008) 4.07

Lambda repressor recognizes the approximately 2-fold symmetric half-operator sequences asymmetrically. Proc Natl Acad Sci U S A (1989) 2.61

The Sec translocase. Biochim Biophys Acta (2010) 2.04

Prokaryotic transcription regulators: more than just the helix-turn-helix motif. Curr Opin Struct Biol (2002) 1.94

Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations. Chem Biol (2010) 1.13

Transcriptome analysis of the secretion stress response of Bacillus subtilis. Appl Microbiol Biotechnol (2005) 1.13

Structural and initial biological analysis of synthetic arylomycin A2. J Am Chem Soc (2007) 1.09

The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase. Proc Natl Acad Sci U S A (2014) 1.08

Inhibitor of streptokinase gene expression improves survival after group A streptococcus infection in mice. Proc Natl Acad Sci U S A (2012) 1.07

Interactions that drive Sec-dependent bacterial protein transport. Biochemistry (2007) 1.07

Arylomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by Streptomyces sp. Tü 6075. I. Taxonomy, fermentation, isolation and biological activities. J Antibiot (Tokyo) (2002) 1.06

Type I signal peptidase and protein secretion in Staphylococcus aureus. J Bacteriol (2012) 1.01

Type I signal peptidase and protein secretion in Staphylococcus epidermidis. J Bacteriol (2010) 0.99

Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I. Antimicrob Agents Chemother (2012) 0.98

In vitro activities of arylomycin natural-product antibiotics against Staphylococcus epidermidis and other coagulase-negative staphylococci. Antimicrob Agents Chemother (2010) 0.96

Improved lux reporters for use in Staphylococcus aureus. Plasmid (2009) 0.94

Initial efforts toward the optimization of arylomycins for antibiotic activity. J Med Chem (2011) 0.90

A putative cro-like repressor contributes to arylomycin resistance in Staphylococcus aureus. Antimicrob Agents Chemother (2015) 0.90

ABC transporters involved in the biogenesis of the outer membrane in gram-negative bacteria. Biosci Biotechnol Biochem (2011) 0.88

Efforts toward broadening the spectrum of arylomycin antibiotic activity. Bioorg Med Chem Lett (2013) 0.81

A conserved streptococcal membrane protein, LsrS, exhibits a receptor-like function for lantibiotics. J Bacteriol (2014) 0.79